This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rose 8.5% to $6.65 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 17,928.14 and the Dow Jones Industrial Average rising 0.6% to 41,368.45.
The stock's rise snapped a three-day losing streak.
Corbus Pharmaceuticals Holdings Inc. closed 89.3% below its 52-week high of $61.90, which the company reached on July 31st.
The stock outperformed some of its competitors, as Vanda Pharmaceuticals Inc. fell 3.7% to $4.22, Fortress Biotech Inc. fell 1.7% to $1.69, and Viking Therapeutics Inc. rose 1.05% to $27.85.
Trading volume totaled 130,386, compared to the 50-day average of 192,667.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 08, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.